MedPath

天津汉瑞药业有限公司

Ownership
-
Established
2010-01-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Benzoylmetronidazole for Suspension

Product Name
苯酰甲硝唑干混悬剂
Approval Number
国药准字H20143286
Approval Date
Aug 12, 2024
NMPA

Compound Paracetamol and Vitamin C Effervescent tablets

Product Name
对乙酰氨基酚维生素C泡腾片
Approval Number
国药准字H20150007
Approval Date
Aug 12, 2024
NMPA

Andrographolide Dispersible Tablets

Product Name
穿心莲內酯分散片
Approval Number
国药准字Z20090059
Approval Date
Nov 3, 2023
NMPA

地榆升白胶囊

Approval Number
国药准字Z20150022
Approval Date
Jan 22, 2020
NMPA

Tropisetron Hydrochloride Injection

Product Name
盐酸托烷司琼注射液
Approval Number
国药准字H20183508
Approval Date
Dec 24, 2018
NMPA

Tropisetron Hydrochloride Injection

Product Name
盐酸托烷司琼注射液
Approval Number
国药准字H20183509
Approval Date
Dec 24, 2018
NMPA

Ozagrel Sodium Injection

Product Name
奥扎格雷钠注射液
Approval Number
国药准字H20183406
Approval Date
Oct 15, 2018
NMPA

Methocarbamol Dispersible Tablets

Product Name
美索巴莫分散片
Approval Number
国药准字H20080273
Approval Date
Mar 12, 2018
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.